What blood tests are indicated for evaluating suspected leukemia in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Tests for Leukemia in Children

For suspected pediatric leukemia, obtain a complete blood count (CBC) with differential and peripheral blood smear as the essential initial blood tests, followed immediately by comprehensive metabolic panel, lactate dehydrogenase (LDH), uric acid, phosphate, and coagulation studies (PT, PTT, fibrinogen) to assess for tumor lysis syndrome and disseminated intravascular coagulation. 1

Initial Required Blood Tests

The diagnostic workup begins with routine laboratory tests on peripheral blood 1:

  • CBC with differential count and peripheral blood smear review - This is mandatory for all suspected cases 1
  • Comprehensive metabolic panel - Critical for monitoring tumor lysis syndrome, particularly in B-lymphoblastic lymphoma 1
  • LDH, uric acid, and phosphate levels - Essential markers of tumor burden and lysis 1
  • Coagulation panel (PT, PTT, fibrinogen) - Required to detect early disseminated intravascular coagulation, especially if acute promyelocytic leukemia is suspected 1

Key Clinical Indicators from Blood Tests

Red flags in initial blood work that strongly suggest leukemia 2, 3:

  • Hemoglobin < 8.5 g/dL (highly predictive)
  • Platelet count < 150,000/μL (highly predictive)
  • White blood cell count patterns (though can be normal in up to 35% of cases initially) 4
  • Elevated LDH > 400 U/L (particularly concerning for neuroblastoma differential) 2

Important caveat: Approximately one-third of pediatric ALL patients present with completely normal CBC at initial presentation 4. Therefore, normal blood counts should never delay oncologic assessment when clinical presentation is suspicious (persistent bone pain, unexplained constitutional symptoms, organomegaly).

Advanced Blood Testing When Peripheral Blood Shows Blasts

If sufficient blasts are present in peripheral blood, the following can be performed directly on blood samples, potentially avoiding immediate bone marrow biopsy 1:

Flow Cytometry Immunophenotyping

  • Multicolor comprehensive flow cytometry panel covering B-ALL, T-ALL, AML, and mixed phenotype acute leukemia (MPAL) 1
  • Peripheral blood flow cytometry has >98% accuracy for pediatric leukemia diagnosis 5
  • Critical exceptions requiring bone marrow confirmation: suspected early T-cell precursor ALL (ETP-ALL), MPAL, and acute megakaryoblastic leukemia (AMKL) - these can show discrepant immunophenotypes between peripheral blood and bone marrow 5

Molecular and Cytogenetic Studies

When peripheral blood contains adequate blasts 1:

  • FISH studies for specific translocations
  • Molecular studies (RT-PCR) for fusion transcripts and mutations
  • Conventional karyotyping (though bone marrow remains preferred)

Specific Testing by Leukemia Subtype

For Childhood ALL (when diagnosed) 1:

Blood-based molecular studies include:

  • RT-PCR for PAX-5, JAK1, JAK2, IKZF1 (B-ALL)
  • BCR-ABL1 fusion products
  • CRLF2 overexpression (B-ALL)
  • NOTCH1 and/or FBXW7 (T-ALL)

For Childhood AML (when diagnosed) 1:

Blood-based molecular studies include:

  • FLT3-ITD, IDH1, IDH2, TET2, WT1, DNMT3A, TP53
  • NPM1, KIT, CEBPA, RUNX1
  • PML-RARA (if acute promyelocytic leukemia suspected)
  • DIC profile mandatory if APL suspected 1

Distinguishing Leukemia from Leukemoid Reaction

Factors favoring leukemia over leukemoid reaction when WBC >50,000/μL 3:

  • Age ≥2 years
  • No known underlying disease
  • WBC ≥60,555/μL
  • Platelet count <118,000/μL
  • LDH ≥781 U/L
  • CRP <0.91 mg/dL

Critical Timing Considerations

The mean time from symptom onset to diagnosis can be 20-40 days 4. When clinical suspicion is high (persistent bone pain, constitutional symptoms, organomegaly), do not wait for hematologic abnormalities to develop - proceed directly to bone marrow examination even with normal peripheral blood counts 4.

Early immunophenotyping can detect disease before morphologic criteria are met: CD10+/TdT+ cells exceeding 10% in bone marrow or 0.03% in peripheral blood strongly suggests smoldering ALL, even when morphology appears normal 6.

Related Questions

What is the appropriate next step in management for a 56‑year‑old man with acute myeloid leukemia who has completed induction therapy and is in hematologic and marrow remission?
What is the likely cause of early‑morning sweats and transient hot flashes in a 56‑year‑old male with acute myeloid leukemia who completed intensive 7+3 chemotherapy, had a normal complete blood count and bone marrow aspirate indicating remission on day 23, was discharged on day 24, and now on day 26 presents with these symptoms?
What is the standard induction therapy for acute myeloid leukemia and how should treatment be modified for older or unfit patients?
What are the possible causes of acute myeloid leukemia presenting suddenly in an 83‑year‑old female?
Which vaccinations are indicated for a 48-year-old man with newly diagnosed chronic lymphocytic leukemia who is already up-to-date on annual influenza vaccine, COVID‑19 boosters, and a recent tetanus‑pertussis booster?
What is the maximum daily dose of enoxaparin (Clexane) for a 64-year-old woman?
Is the diabetic ketoacidosis (DKA) protocol for pregnant women different from that for non‑pregnant patients?
How do Hemadid (ferrous sulfate), Globifer (heme iron polypeptide), and Fefol Spansule (ferrous fumarate) compare regarding elemental iron content, absorption, clinical efficacy, and side‑effect profile?
What are the atypical or extra‑esophageal manifestations of gastroesophageal reflux disease (GERD)?
What is the recommended initial management of acute pancreatitis?
What is the appropriate management for a patient with hyperthyroidism who is developing an impending thyroid storm?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.